Use fundamental data analysis to confirm all available drivers of ResMed to find out if markets are presently mispricing the firm. We found thirty-six available financial ratios for ResMed which can be compared to its competitors. To make sure the equity is not overpriced, please check all ResMed fundamentals including its Book Value Per Share, Retained Earnings and the relationship between Cash per Share and Number of Employees . Given that ResMed has Price to Earning of 50.92 times, we recommend you check out ResMed recent market performance to make sure the company can sustain itself down the road.Use ResMed to protect against small markets fluctuations. The stock experiences somewhat bearish sentiment, but market may correct it shortly. Check odds of ResMed to be traded at $95.84 in 30 days
ResMed competes with DexCom, Cooper Companies, Quest Diagnostics, DENTSPLY SIRONA, and RESMED INC. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in USA and traded on New York Stock Exchange. It employs 6000 people.
ResMed is rated below average in revenue category among related companies. It is rated fifth in retained earnings category among related companies reporting about 0.98 of Retained Earnings per Revenue. The ratio of Revenue to Retained Earnings for ResMed is roughly 1.02
ResMed Systematic Risk
The output start index for this execution was twenty with a total number of output elements of nineteen. The Beta measures systematic risk based on how returns on ResMed correlated with the market. If Beta is less than 0 ResMed generally moves in the opposite direction as compared to the market. If ResMed Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ResMed is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ResMed is generally in the same direction as the market. If Beta > 1 ResMed moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.
ResMed Financial Distress Probability
Chance of Financial Distress
ResMed has less than 6 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info